UCSF Center for HIV Information

University of California, San Francisco

1700 Owens Street, Suite 316
San Francisco, CA 94158
United States

Articles: 36

Title Sort descending Publish date Review date
Bictegravir Approved for Initial ART, in Combination with TAF/FTC
Bictegravir/TAF/FTC in Women
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study
Dolutegravir + 3TC in Initial Therapy
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine
HIV Meds Update - RAPID: Immediate ART Initiation
HIV Meds Update: Anal Dysplasia Treatment Prevents Anal Cancer - The ANCHOR Study
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA
HIV Meds Update: DoxyPEP – Doxycycline for STI Prevention
HIV Meds Update: FDA Approves Lenacapavir, New Long-Acting Injectable ARV
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART
HIV Meds Updates: Long-acting Injectable Therapy: Lenacapavir
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Immediate ART Initiation Improves Time to Viral Suppression
Long-Acting Injectable ART: Cabotegravir + Rilpivirine
Long-acting Injectable PrEP Approved: Cabotegravir
Long-acting Injectable PrEP: Cabotegravir
Naltrexone Improves Virologic Suppression
New ARV Approval - Fostemsavir
PrEP: Bone Density Improves after Stopping TDF/FTC
PrEP: TDF/FTC vs TAF/FTC in MSM
Rapid ART Start
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Safety of Dolutegravir at Conception: Updated Data
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
Switching from TDF/FTC to TAF/FTC
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Tissue Levels of TAF: Too Low for PrEP?
Updated CDC PrEP Guidelines
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Updates on Mpox: Vaccination Efficacy and Spectrum of Disease in People with HIV
Use of Dolutegravir in Dialysis